Ptc Therapeutics (PTCT) Current Leases (2019 - 2026)
Ptc Therapeutics (PTCT) posted quarterly Current Leases of $12.0 million for Q2 2026, up 2.05% year-over-year from $11.7 million in Q2 2025, and down 0.94% quarter-over-quarter from $12.1 million in Q1 2026.
Ptc Therapeutics (PTCT) Current Leases (2019 - 2026) Analysis & Trends
Ptc Therapeutics' Current Leases history runs 8 years deep, the most recent figure standing at $12.0 million for Q2 2026.
- In Q2 2026, Current Leases rose 2.05% year-over-year to $12.0 million; the TTM figure through Jun 2026 stood at $12.0 million (up 2.05% YoY), while the FY2025 annual figure was $12.5 million, up 20.47% from the prior year.
- Current Leases for Q2 2026 stood at $12.0 million, down from $12.1 million in the prior quarter.
- The five-year high for Current Leases was $14.6 million in Q1 2024, with the low at $7.4 million in Q1 2022.
- The 5-year median for Current Leases is $11.7 million (2023), against an average of $11.3 million.
- The sharpest annual moves came in 2024 and 2025: Current Leases surged 51.82% in 2024, then decreased 21.33% in 2025.
- Ptc Therapeutics' Current Leases stood at $9.4 million in 2022, then surged by 38.76% to $13.0 million in 2023, then decreased by 20.3% to $10.4 million in 2024, then gained by 20.47% to $12.5 million in 2025, then decreased by 4.16% to $12.0 million in 2026.
- Business Quant data shows PTCT's Current Leases at $12.0 million in Q2 2026, $12.1 million in Q1 2026, and $12.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Ptc Therapeutics | 5.97 Bn | 3.75 Bn | 340.60 Mn | 11.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.97 Mn |
| Mar 31, 2026 | 6.00 Mn |
| Dec 31, 2025 | 3.00 Mn |
| Sep 30, 2025 | 2.68 Mn |
| Jun 30, 2025 | 5.36 Mn |
| Mar 31, 2025 | 11.46 Mn |
| Dec 31, 2024 | 3.00 Mn |
| Sep 30, 2024 | 14.11 Mn |
| Jun 30, 2024 | 2.29 Mn |
| Mar 31, 2024 | 14.57 Mn |
| Dec 31, 2023 | 3.00 Mn |
| Sep 30, 2023 | 2.61 Mn |
| Jun 30, 2023 | 2.23 Mn |
| Mar 31, 2023 | 9.60 Mn |
| Dec 31, 2022 | 9.37 Mn |
| Sep 30, 2022 | 2.60 Mn |
| Jun 30, 2022 | 8.90 Mn |
| Mar 31, 2022 | 1.77 Mn |
| Dec 31, 2021 | 7.27 Mn |
| Sep 30, 2021 | 7.14 Mn |